Skip to content

To evaluate efficacy and safety of tooth powder.

A Prospective, Open-label, Interventional Study to Evaluate the Efficacy and Safety of Tooth Powder in Improving Oral Health Outcomes in Adults with Common Dental and Gum Disorders - NA

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091603
Enrollment
60
Registered
2025-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K089- Disorder of teeth and supporting structures, unspecified

Interventions

None listed

Sponsors

Dabur India Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants will be eligible for inclusion in the study if they meet all of the following criteria- 1) Age 18 65 years, of either sex, who are willing and able to comply with study procedures and follow-up. 2) Clinical diagnosis of mild to moderate chronic gingivitis or periodontitis. 3) Presence of at least 20 natural teeth, including 2 or more posterior teeth in each arch. 4) History of one or more of the symptoms for 2 or more weeks.

Exclusion criteria

Exclusion criteria: Participants will be excluded from the study if they meet any of the following criteria Severe Active dental infections or abscesses requiring immediate antibiotic or surgical treatment. Known hypersensitivity or allergy to any component of the investigational tooth powder. Use of other medicated oral care products, such as desensitizing or antibacterial toothpaste/mouthwash, within the past 2 weeks or unwilling to discontinue during the study. Pregnant or breastfeeding women. Participation in another clinical trial or use of investigational products within the last 30 days. Any other condition which, in the opinion of the investigator, may interfere with the conduct or interpretation of the study.

Design outcomes

Primary

MeasureTime frame
Relief from symptoms of pyorrheaTimepoint: 3 months

Secondary

MeasureTime frame
relief from dentine sensitivity, toothacheTimepoint: 3 months

Countries

India

Contacts

Public ContactDr Baidyanath Mishra

The Dental Planet

dr.subasish@gmail.com9937034576

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026